HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion

Journal:

Science Advances

Published:

2025-09-05

DOI:

10.1126/sciadv.ady1289

Affiliations:

10

Authors:

12

Go to article

Institutions	Authors	Share
Turku Bioscience Centre, Finland	4.166667	0.35
Åbo Akademi University, Finland	3.666667	0.31
Turku University Hospital (TYKS), UTU, Finland	2.000000	0.17
Innovation Ecosystem based on the Immune System (InFLAMES Flagship), Finland	0.833333	0.07
University of Turku (UTU), Finland	0.500000	0.04
FICAN West, Finland	0.500000	0.04
Lapland Central Hospital, LSHP, Finland	0.333333	0.03

Interested in Oncology and Carcinogenesis?